348 related articles for article (PubMed ID: 12877584)
1. Synthesis and structure-activity relationship of a new series of COX-2 selective inhibitors: 1,5-diarylimidazoles.
Almansa C; Alfón J; de Arriba AF; Cavalcanti FL; Escamilla I; Gómez LA; Miralles A; Soliva R; Bartrolí J; Carceller E; Merlos M; García-Rafanell J
J Med Chem; 2003 Jul; 46(16):3463-75. PubMed ID: 12877584
[TBL] [Abstract][Full Text] [Related]
2. 1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents.
Khanna IK; Weier RM; Yu Y; Xu XD; Koszyk FJ; Collins PW; Koboldt CM; Veenhuizen AW; Perkins WE; Casler JJ; Masferrer JL; Zhang YY; Gregory SA; Seibert K; Isakson PC
J Med Chem; 1997 May; 40(11):1634-47. PubMed ID: 9171873
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.
Song Y; Connor DT; Sercel AD; Sorenson RJ; Doubleday R; Unangst PC; Roth BD; Beylin VG; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1161-9. PubMed ID: 10197960
[TBL] [Abstract][Full Text] [Related]
4. Amide derivatives of [5-chloro-6-(2-chloro/fluorobenzoyl)-2-benzoxazolinone-3-yl]acetic acids as potential analgesic and anti-inflammatory compounds.
Banoglu E; Okçelik B; Kupeli E; Unlü S; Yeşilada E; Amat M; Caturla JF; Sahin MF
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):251-7. PubMed ID: 12916060
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).
Penning TD; Talley JJ; Bertenshaw SR; Carter JS; Collins PW; Docter S; Graneto MJ; Lee LF; Malecha JW; Miyashiro JM; Rogers RS; Rogier DJ; Yu SS; AndersonGD ; Burton EG; Cogburn JN; Gregory SA; Koboldt CM; Perkins WE; Seibert K; Veenhuizen AW; Zhang YY; Isakson PC
J Med Chem; 1997 Apr; 40(9):1347-65. PubMed ID: 9135032
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulation.
Pal M; Madan M; Padakanti S; Pattabiraman VR; Kalleda S; Vanguri A; Mullangi R; Mamidi NV; Casturi SR; Malde A; Gopalakrishnan B; Yeleswarapu KR
J Med Chem; 2003 Sep; 46(19):3975-84. PubMed ID: 12954051
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of substituted 2-alkylthio-1,5-diarylimidazoles as selective COX-2 inhibitors.
Navidpour L; Shadnia H; Shafaroodi H; Amini M; Dehpour AR; Shafiee A
Bioorg Med Chem; 2007 Mar; 15(5):1976-82. PubMed ID: 17258905
[TBL] [Abstract][Full Text] [Related]
9. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
Gierse JK; Zhang Y; Hood WF; Walker MC; Trigg JS; Maziasz TJ; Koboldt CM; Muhammad JL; Zweifel BS; Masferrer JL; Isakson PC; Seibert K
J Pharmacol Exp Ther; 2005 Mar; 312(3):1206-12. PubMed ID: 15494548
[TBL] [Abstract][Full Text] [Related]
10. Investigations of new pyridazinone derivatives for the synthesis of potent analgesic and anti-inflammatory compounds with cyclooxygenase inhibitory activity.
Okçelik B; Unlü S; Banoglu E; Küpeli E; Yeşilada E; Sahin MF
Arch Pharm (Weinheim); 2003 Sep; 336(9):406-12. PubMed ID: 14528488
[TBL] [Abstract][Full Text] [Related]
11. Diarylspiro[2.4]heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationships.
Huang HC; Li JJ; Garland DJ; Chamberlain TS; Reinhard EJ; Manning RE; Seibert K; Koboldt CM; Gregory SA; Anderson GD; Veenhuizen AW; Zhang Y; Perkins WE; Burton EG; Cogburn JN; Isakson PC; Reitz DB
J Med Chem; 1996 Jan; 39(1):253-66. PubMed ID: 8568815
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
[TBL] [Abstract][Full Text] [Related]
14. ABT-963 [2-(3,4-difluoro-phenyl)-4-(3-hydroxy-3-methyl-butoxy)-5-(4-methanesulfonyl-phenyl)-2H-pyridazin-3-one], a highly potent and selective disubstituted pyridazinone cyclooxgenase-2 inhibitor.
Harris RR; Black L; Surapaneni S; Kolasa T; Majest S; Namovic MT; Grayson G; Komater V; Wilcox D; King L; Marsh K; Jarvis MF; Nuss M; Nellans H; Pruesser L; Reinhart GA; Cox B; Jacobson P; Stewart A; Coghlan M; Carter G; Bell RL
J Pharmacol Exp Ther; 2004 Dec; 311(3):904-12. PubMed ID: 15277581
[TBL] [Abstract][Full Text] [Related]
15. 1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2.
Khanna IK; Weier RM; Yu Y; Collins PW; Miyashiro JM; Koboldt CM; Veenhuizen AW; Currie JL; Seibert K; Isakson PC
J Med Chem; 1997 May; 40(11):1619-33. PubMed ID: 9171872
[TBL] [Abstract][Full Text] [Related]
16. Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents.
Khanna IK; Yu Y; Huff RM; Weier RM; Xu X; Koszyk FJ; Collins PW; Cogburn JN; Isakson PC; Koboldt CM; Masferrer JL; Perkins WE; Seibert K; Veenhuizen AW; Yuan J; Yang DC; Zhang YY
J Med Chem; 2000 Aug; 43(16):3168-85. PubMed ID: 10956225
[TBL] [Abstract][Full Text] [Related]
17. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.
Kalgutkar AS; Kozak KR; Crews BC; Hochgesang GP; Marnett LJ
J Med Chem; 1998 Nov; 41(24):4800-18. PubMed ID: 9822550
[TBL] [Abstract][Full Text] [Related]
18. New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position.
Janusz JM; Young PA; Ridgeway JM; Scherz MW; Enzweiler K; Wu LI; Gan L; Chen J; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL
J Med Chem; 1998 Aug; 41(18):3515-29. PubMed ID: 9719605
[TBL] [Abstract][Full Text] [Related]
19. New water-soluble sulfonylphosphoramidic acid derivatives of the COX-2 selective inhibitor cimicoxib. A novel approach to sulfonamide prodrugs.
Almansa C; Bartrolí J; Belloc J; Cavalcanti FL; Ferrando R; Gómez LA; Ramis I; Carceller E; Merlos M; García-Rafanell J
J Med Chem; 2004 Oct; 47(22):5579-82. PubMed ID: 15481993
[TBL] [Abstract][Full Text] [Related]
20. Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents.
Li JJ; Norton MB; Reinhard EJ; Anderson GD; Gregory SA; Isakson PC; Koboldt CM; Masferrer JL; Perkins WE; Seibert K; Zhang Y; Zweifel BS; Reitz DB
J Med Chem; 1996 Apr; 39(9):1846-56. PubMed ID: 8627608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
